Mercaptopurine Tablets(China Resources Double-Crane Pharma)

巯嘌呤微片(华润双鹤药业)

Report date: 2026/03/31 20:00:21

Base Information

Drug NameMercaptopurine Tablets(China Resources Double-Crane Pharma)
Drug Alias Name6-巯基嘌呤6巯基嘌呤巯嘌呤(2.2改良型)乐疾宁麦卡累金 +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxanthine-guanine phosphoribosyltransferase inhibitors
TargetsHypoxanthine-guanine phosphoribosyltransferase
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Approved Indications in ChinaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Original Approved Country/TerritoryMainland China
Original Approved Date2025/01/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A